Multiple Sclerosis Trial, Recruiting NCT07175792 Sponsor: Hasselt University Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT07175792
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 70 years old
  • You are able to walk for 6 minutes without stopping or needing a walking stick or other walking aid
  • You are able to repeatedly stand up from and sit down on a standard chair (about 43cm high) without using your hands for support

For people with Multiple Sclerosis (MS) specifically:

  • You have been diagnosed with MS according to recognised medical guidelines (confirm with trial site)
  • You have not had an MS relapse (a flare-up of symptoms) in the month before the study begins

Who may not be able to join:

  • You have difficulties with memory or thinking that would make it hard to understand the study instructions
  • You are pregnant or think you might be pregnant
  • You have a condition affecting the muscles, bones, or joints in your legs or lower body
  • You have certain heart or cardiovascular health concerns that mean exercise may not be safe for you (this will be checked using a standard health questionnaire)
  • You have another diagnosed neurological condition (affecting the brain or nerves) or a metabolic condition (affecting how your body processes energy) that would prevent you from completing the study tests fully

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hasselt University
Registry
ClinicalTrials.gov
Start date
9 December 2024
Est. completion
16 October 2025

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Perceptive Sensitivity; Detection Accuracy; Correspondence Accuracy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov